SCHEMBL7865240

SCHEMBL7865240

Cc1cccc(NC(=O)NC2CC(c3ccccc3C)CC(c3ccccc3)N(CC(=O)O)C2=O)c1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8920182 0.82 CCKBR (0.77) CCKBR
SCHEMBL8922128 0.82 CCKBR (0.61) CCKBR
SCHEMBL7865149 0.82 CCKBR (0.85) CCKBR
SCHEMBL8921507 0.81 CCKBR (1.00) CCKBR
SCHEMBL8399449 0.80 CCKBR (0.82) CCKBR
SCHEMBL7874167 0.78 CCKBR (0.75) CCKBR
SCHEMBL7874284 0.78 CCKBR (0.74) CCKBR
SCHEMBL9544016 0.78 CCKBR (0.81) CCKBR
SCHEMBL8922870 0.77 CCKBR (1.00) CCKBR
SCHEMBL8975347 0.76 CCKBR (0.86) CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6319915-B1 ADMINISTERING BENZAZEPIENE DERIVATIVE TO MAMMAL FOR THERAPY OF CANCER PFIZER INC. 2001-11-20 US claimed
US-6319915-B1 ADMINISTERING BENZAZEPIENE DERIVATIVE TO MAMMAL FOR THERAPY OF CANCER PFIZER INC. 2001-11-20 US disclosed